Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05098340

Circulating circRNA in Acute Ischemic Stroke

Clinical Significance of Circulating circRNA in Acute Ischemic Stroke (CRAST)

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
The Affiliated Hospital of Xuzhou Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

CRAST is to analyze the expression pattern of circular RNA (circRNA) by bioinformatics analysis in patients with acute ischemic stroke and healthy control. The candidate circRNA will be verified as biomarkers for the detection and prognosis of acute ischemic stroke.

Detailed description

Circular RNAs have been highlighted to be involved in the pathological process of ischemic stroke (IS). The purpose of this protocol will investigate the expression pattern of circular RNA (circRNA) by bioinformatics analysis in patients with acute ischemic stroke and healthy control. The candidate circRNA will be verified as biomarkers for the detection and prognosis of acute ischemic stroke. Distinctive expression patterns of circRNA will be identified by individual quantitative real time polymerase chain reaction (qRT-PCR). A diagnostic or predictive model will be established using logistic regression. The panel of these altered circRNAs may be associated with acute IS and could serve as a novel diagnostic or predictive method.

Conditions

Interventions

TypeNameDescription
GENETICQuantitative Real-time polymerase chain reactionQuantitative Real-time polymerase chain reaction of circular RNA (circRNA).

Timeline

Start date
2020-10-01
Primary completion
2024-10-30
Completion
2024-10-30
First posted
2021-10-28
Last updated
2024-08-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05098340. Inclusion in this directory is not an endorsement.

Circulating circRNA in Acute Ischemic Stroke (NCT05098340) · Clinical Trials Directory